Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer February 2018 18(1):e135-e142 - Subject
- Language
- ISSN
- 1526-8209